Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Epoetin Beta Target Haemoglobin Levels in Anaemia of Diabetic Nephropathy
2006-004775-35Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Nov 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of epoetin beta in anaemia, diabetic glomerulosclerosis and chronic kidney disease (CKD) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Rate of decline of renal function. Started Nov 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
anaemiadiabetic glomerulosclerosischronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-004775-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004775-35.